Coronary Occlusion
Conditions
Keywords
Chronic Coronary Occlusion, Peripheral Component Interconnect, Coronary angioplasty
Brief summary
Data from the literature on the management of Chronic Coronary Occlusions (CTO) in France highlight a lack of epidemiological data on these patients at the national level. For this reason, it was decided to set up this large-scale survey in order to have a picture of the management of patients with chronic coronary occlusion in France, to study the prevalence of CTOs in France as well as their management (medical, surgical or interventional), and then by analysing more precisely, over a second survey period, CTO angioplasties in terms of success rates, complications, medico-economic impact.
Detailed description
This exhaustive and descriptive study of CTO patients, performed on a set of approximately 100 interventional cardiology centers in France, will be conducted in two steps: * 1st step: This collection will be done over one month, the objective of which will be to photograph the therapeutic choice in the management of CTO (drug, surgical, endovascular approach). * 2nd step: a second collection will be carried out over a period of two months, the objective of which will be to evaluate, in patients presenting a CTO with an attempt at angioplasty, the success of the procedure.
Interventions
None listed
Sponsors
French Cardiology Society
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Phase I Inclusion Criteria: * Patient over 18 years old * Patient with CTO
Exclusion criteria
* Patient with acute occlusion or subocclusive lesion or CTO of less than 3 months * Patient expressing his refusal to participate in the observatory Phase II Inclusion Criteria: * Patient over 18 years old * Patient with CTO who has attempted angioplasty
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Choice of treatment in management of patients with CTO | Through the end of hospitalization, an average of 5 days | Rate of patients with CTO treated by medical treatment alone and/or by surgery, and/or by angioplasty |
| Success of the angioplasty for management of CTO | Through the end of hospitalization, an average of 5 days | Procedural success rate defined by residual stenosis ≤ 30% with a TIMI (Thrombolysis In Myocardial Infarction) 3 flow and no hospital complications at the end of the angioplasty procedure |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Rate of events occured after procedure of angioplasty during the hospitalization, for patients with CTO | Through the end of hospitalization, an average of 5 days | Major Adverse Cardiac and Cerebrovascular Events (MACCE - defined as the composite of death, Myocardial Infarction (MI), CerebroVascular Accident (CVA) or Stroke, or Target Vessel Revascularisation (TVR)) |
Countries
France
Outcome results
None listed